ArticleBMC geriatrics2025
Association between blood urea nitrogen-to-albumin ratio and mortality in ICU patients with chronic obstructive pulmonary disease: data from the MIMIC IV database.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aims to investigate the association between blood urea nitrogen to albumin ratio (BAR) and short- and long-term mortality among intensive care unit (ICU) patients with chronic obstructive pulmonary disease (COPD).
methodsPatients diagnosed with COPD based on International Classification of Diseases 9th and 10th Revisions diagnosis codes in the Medical Information Mart for Intensive Care IV (version 2.2) database were screened. Outcomes included 28-day, 90-day, 180-day, and 1-year mortality after ICU admission. Receiver operating characteristic (ROC) curve, concordance index (C-index), Kaplan–Meier (K–M) survival curve, logistic regression analyses, and subgroup analysis were performed to assess the clinical utility of BAR.
resultsThis study included 1,067 patients. The 28-day, 90-day, 180-day, and 1-year mortality rates were 24.9%, 31.8%, 37.3%, and 44.8%, respectively. The ROC curve analysis and C-index indicated that admission BAR had moderate predictive ability for short- and long-term all-cause mortality in critically ill patients with COPD. Logistic regression revealed that BAR was an independent adverse predictor for short- and long-term mortality. K–M curves indicated a significant difference in short- and long-term survival (p < .001) among different BAR groups. No significant interaction was observed by subgroup analysis across all subgroups stratified by comorbidities.
conclusionThis study demonstrated that an elevated BAR is significantly associated with increased short- and long-term mortality among critically ill patients with COPD admitted to the ICU. Given its availability and low cost, BAR may serve as a practical prognostic tool in clinical settings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.